Hubble Therapeutics

Developer of a gene therapy platform designed for a rare genetic eye disorder that typically presents with severe progressive visual impairment. The company's proprietary gene therapy treats leber con...

Healthcare

Hanover, NH, United States

Founded 2000

2 employees

Website

Valuation

Share Price

N/A

Total Raised

$20.3M

Last Round

N/A

Investors

+4 other investors

View all 4 investors

Valuation History

0 funding rounds on record

Cap Table

Ownership structure

Market Activity

Secondary transactions

Get the full picture

Create a free account to unlock Hubble Therapeutics's funding history, team members, investor details, and more.

15 free profiles/month · No credit card required